REVERSAL OR NITROGLYCERIN TOLERANCE BY THE CGMP PHOSPHODIESTERASE INHIBITOR ZAPRINAST

被引:24
作者
SILVER, PJ
PAGANI, ED
DEGARAVILLA, L
VANALLER, GS
VOLBERG, ML
PRATT, PF
BUCHHOLZ, RA
机构
[1] Department of Cardiovascular Pharmacology, Sterling Research Group, Rensselaer
关键词
D O I
10.1016/0014-2999(91)90652-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:141 / 142
页数:2
相关论文
共 4 条
[1]   NITRATE TOLERANCE FROM A BIOCHEMICAL POINT-OF-VIEW [J].
AXELSSON, KL ;
AHLNER, J .
DRUGS, 1987, 33 :63-68
[2]   SODIUM-NITROPRUSSIDE POTENTIATES THE DEPRESSOR RESPONSE TO THE PHOSPHODIESTERASE INHIBITOR ZAPRINAST IN RATS [J].
DUNDORE, RL ;
PRATT, PF ;
HALLENBECK, WD ;
WASSEY, ML ;
SILVER, PJ ;
BUCHHOLZ, RA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 185 (01) :91-97
[3]  
HARRIS AL, 1989, J PHARMACOL EXP THER, V249, P394
[4]   S-NITROSOTHIOLS AS VASODILATORS - IMPLICATIONS REGARDING TOLERANCE TO NITRIC OXIDE-CONTAINING VASODILATORS [J].
HENRY, PJ ;
DRUMMER, OH ;
HOROWITZ, JD .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (03) :757-766